tiprankstipranks
Trending News
More News >

Mesoblast Limited Announces Cessation of Securities

Story Highlights
Mesoblast Limited Announces Cessation of Securities

Confident Investing Starts Here:

The latest update is out from Mesoblast Limited ( (AU:MSB) ).

Mesoblast Limited has announced the cessation of 30,000 securities due to the lapse of conditional rights, as the conditions were not met or became incapable of being satisfied. This announcement may impact the company’s capital structure and could have implications for its stakeholders, reflecting the challenges in meeting certain operational conditions.

More about Mesoblast Limited

Mesoblast Limited operates in the biotechnology industry, focusing on the development and commercialization of innovative cellular medicines. The company specializes in regenerative medicine, aiming to address significant unmet medical needs across various therapeutic areas.

YTD Price Performance: -31.82%

Average Trading Volume: 417,938

Technical Sentiment Signal: Strong Sell

Current Market Cap: $1.26B

For detailed information about MSB stock, go to TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App